On-demand
HAE
therapy in a pill

EKTERLY is the first and only oral
on-demand therapy
to treat hereditary angioedema (HAE) attacks.

Stay updated

Get Started

This Start Form should be completed by a healthcare provider to prescribe EKTERLY.
Please choose from the two options below to complete your Start Form.

Option 1

Submit the Start Form online.

Coming soon

Option 2

Download a PDF form to fill out and fax it to 844-432-9525.

Download form

A patient support program for people
taking EKTERLY

Your next dose is already in reach. From enrollment to refill, we're with you every step of the way.

Living with hereditary angioedema (HAE) can bring unique challenges, and
at KalVista Cares, we understand how important it is to feel supported. That’s
why our dedicated Care Managers are here to assist you through every step of
your treatment journey with EKTERLY.

Navigating access and insurance

We know that navigating insurance coverage and accessing the right resources for HAE treatment can be complicated. KalVista Cares is here to help with tailored support, including help exploring financial assistance options and minimizing any delays or disruptions in starting or continuing EKTERLY.

Continuous support

From getting started with your treatment to staying on track, KalVista Cares is committed to providing personalized, ongoing support. Whether it’s helping you access EKTERLY or answering questions you may have along the way, our program is here for you every step of the way.

Once enrolled, your dedicated Care Manager can:

Provide you with information about financial options
Explain your insurance benefits
Work with your specialty pharmacy to help ensure you receive your treatment
Connect you to educational resources and HAE advocacy groups

With the KalVista Cares
Co-Pay Assistance Program,
eligible commercially insured patients
may pay as little as $0 for their
EKTERLY prescription.^*†

To be eligible, you must:

Have commercial insurance (commercial insurance does not include Medicare, Medicaid,
Veterans Affairs (VA), or other federal or state health plans)
Be enrolled in the KalVista Cares Patient Support Program

Your Care Manager will review your insurance coverage with you and determine if you are eligible for the KalVista Cares Co-Pay Assistance Program.^*†

Up to an annual maximum benefit of $40,000. Terms and conditions apply.

IMPORTANT NOTICE
This co-pay assistance program is intended only for eligible patients with commercial (private) insurance. Patients with government-funded insurance, such as Medicare, Medicaid, TRICARE, or any state or federal health insurance program, are not eligible to participate. Participation in the program is subject to eligibility requirements and program limits. The program may cover a portion or all of the patient’s out-of-pocket costs up to a maximum amount determined by the program. Terms and conditions may change from time to time, or the program may be discontinued at any time without notice. By participating, patients agree to comply with all terms and conditions.

Hypothetical patient holding an EKTERLY® (sebetralstat) tablet

Treatment that goes where you do

Stay up to date
with information about EKTERLY

*Indicates required field

First Name*

Last Name*

E-Mail Address*

ZIP Code*

I am a*

Patient Caregiver HCP

IMPORTANT SAFETY INFORMATION

Before taking EKTERLY, tell your healthcare provider about all of your medical conditions, including if you:

Are pregnant or planning to become pregnant. It is not known if EKTERLY can harm your unborn baby.

Are breastfeeding or plan to breastfeed. It is not known if EKTERLY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking EKTERLY.

Have severe liver problems.

Tell your healthcare provider about all of the medicines you take, including other medicines for HAE, prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take any of the following, as your healthcare provider may need to change the dose of EKTERLY: itraconazole, phenytoin, efavirenz.

Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.

What are the possible side effects of EKTERLY?

The possible side effects of EKTERLY include headache. For more information, ask your healthcare provider or pharmacist. Talk to your doctor for medical advice about side effects.

You are encouraged to report side effects related to KalVista products by calling 1-855-258-4782. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

On-demand
HAE
therapy in a pill